Osivax logo

Osivax

Osivax is a clinical-stage biopharmaceutical company leveraging its novel, self-assembling nanoparticle platform technology, oligoDOM, to develop transformative, first-in-class pan-respiratory virus vaccines generating superior T-cell responses in addition to strong and sustained B-cell responses. T... Read more

Headquarters

France

Employees

51-200

Links


Org chart

Collapse
No reports!

Teams


Offices